Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nivalis Therapeutics, Inc. | 200,000 | reported | 12 Jan 2017 | tx 4+389,400 |
| Edgewise Therapeutics, Inc. | 86,162 | reported | 12 Aug 2025 | tx 36+1,182,099−517,801 |
| VICAL INC | 10,000 | reported | 16 Mar 2020 | tx 1+10,000 |
| OnKure Therapeutics, Inc. | 7,650 | reported | 28 May 2025 | tx 6+30,973 |
| Elevation Oncology, Inc. | 0 | reported | 23 Jul 2025 | tx 9+116,857−164,187 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Aug 2025 | EXERCISE | Edgewise Therapeutics, Inc. | 5,781 | 0.00 USD | |
| 12 Aug 2025 | SALE | Edgewise Therapeutics, Inc. | 1,428 | 13.39 USD | |
| 12 Aug 2025 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 26,875 | 0.00 USD | deriv |
| 12 Aug 2025 | EXERCISE | Edgewise Therapeutics, Inc. | 5,781 | 0.00 USD | deriv |
| 12 Aug 2025 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 161,250 | 0.00 USD | deriv |
| 23 Jul 2025 | OTHER | Elevation Oncology, Inc. | 31,238 | 0.00 USD | deriv |
| 23 Jul 2025 | OTHER | Elevation Oncology, Inc. | 35,000 | 0.00 USD | deriv |
| 23 Jul 2025 | OTHER | Elevation Oncology, Inc. | 15,619 | 0.00 USD | deriv |
| 23 Jul 2025 | OTHER | Elevation Oncology, Inc. | 35,000 | 0.00 USD | deriv |
| 23 Jul 2025 | OTHER | Elevation Oncology, Inc. | 47,330 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Elevation Oncology, Inc. | 35,000 | 0.00 USD | deriv |
| 28 May 2025 | GRANT_AWARD | OnKure Therapeutics, Inc. | 7,650 | 0.00 USD | deriv |
| 01 May 2025 | EXERCISE | Edgewise Therapeutics, Inc. | 5,209 | 0.00 USD | |
| 02 May 2025 | SALE | Edgewise Therapeutics, Inc. | 1,314 | 16.45 USD | |
| 01 May 2025 | EXERCISE | Edgewise Therapeutics, Inc. | 5,209 | 0.00 USD | deriv |
| 11 Oct 2024 | EXERCISE | Edgewise Therapeutics, Inc. | 70,000 | 0.71 USD | |
| 11 Oct 2024 | EXERCISE | Edgewise Therapeutics, Inc. | 70,000 | 0.00 USD | deriv |
| 04 Oct 2024 | GRANT_AWARD | OnKure Therapeutics, Inc. | 4,065 | — | |
| 04 Oct 2024 | GRANT_AWARD | OnKure Therapeutics, Inc. | 874 | — | |
| 04 Oct 2024 | GRANT_AWARD | OnKure Therapeutics, Inc. | 1,760 | — | deriv |
| 04 Oct 2024 | GRANT_AWARD | OnKure Therapeutics, Inc. | 1,324 | — | deriv |
| 04 Oct 2024 | GRANT_AWARD | OnKure Therapeutics, Inc. | 15,300 | 0.00 USD | deriv |
| 20 Sept 2024 | SALE | Edgewise Therapeutics, Inc. | 4,064 | 28.59 USD | |
| 20 Sept 2024 | EXERCISE | Edgewise Therapeutics, Inc. | 46,068 | 1.93 USD | |
| 20 Sept 2024 | SALE | Edgewise Therapeutics, Inc. | 46,068 | 28.59 USD |